Comprehensive Geriatric Assessment in the Management of Older Patients With Cardiovascular Disease.


Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
06 2020
Historique:
received: 22 02 2019
revised: 29 08 2019
accepted: 04 09 2019
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 2 10 2020
Statut: ppublish

Résumé

Cardiovascular disease (CVD) disproportionately affects older adults. It is expected that by 2030, one in five people in the United States will be older than 65 years. Individuals with CVD now live longer due, in part, to current prevention and treatment approaches. Addressing the needs of older individuals requires inclusion and assessment of frailty, multimorbidity, depression, quality of life, and cognition. Despite the conceptual relevance and prognostic importance of these factors, they are seldom formally evaluated in clinical practice. Further, although these constructs coexist with traditional cardiovascular risk factors, their exact prevalence and prognostic impact remain largely unknown. Development of the right decision tools, which include these variables, can facilitate patient-centered care for older adults. These gaps in knowledge hinder optimal care use and underscore the need to rigorously evaluate the optimal constructs for providing care to older adults. In this review, we describe available tools to examine the prognostic role of age-related factors in patients with CVD.

Identifiants

pubmed: 32498778
pii: S0025-6196(19)30766-9
doi: 10.1016/j.mayocp.2019.09.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231-1252

Informations de copyright

Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Mandeep Singh (M)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address: singh.mandeep@mayo.edu.

John A Spertus (JA)

Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO.

Shahyar M Gharacholou (SM)

Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL.

Rakesh C Arora (RC)

Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Robert J Widmer (RJ)

Baylor Scott & White Health, Temple, TX.

Amrit Kanwar (A)

University of Iowa Carver College of Medicine, Iowa City, IA.

Rohan M Sanjanwala (RM)

Cardiac Sciences Program, St. Boniface Hospital, Winnipeg, Manitoba, Canada.

Garrett A Welle (GA)

University of Minnesota Medical School, Minneapolis, MN.

Mohammed A Al-Hijji (MA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH